Baxter completed the separation process of its Korea branch, launching ‘Baxalta’
The separation process of a biopharmaceutical company from the Baxter’s Korean branch has been completed.
According to the industry concerned on the 6th, Baxter Korea turned in reports registering a merger and a new corporate to the Fair Trade Commission this early-year, completed preparation of...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
